Press Releases

May 10, 2010
Coronado Appoints COO and CFO

Jan. 28, 2008
Study shows Coronado Biosciences’ Bcl-2 inhibitor, apogossypol, is more efficacious, less toxic than gossypol in animal models

Jan. 7, 2008
Coronado initiates Phase I clinical trial of rationally designed fourth generation doxorubicin analogue

May 30, 2007
Coronado Biosciences and Burnham Institute for Medical Research sign exclusive worldwide license agreement to develop and commercialize apogossypol for the treatment of cancer

Company and Developments News

November 28, 2009
Joanne Scott had become first in the world to get a cure from cancer with tumor- activated natural killer cells. The new treatment succeeded where the others

November 28, 2009
Blood cells from Joanne Scott's 21-year-old daughter Tara were ... NK cells are a type of immune cell that kill tumours and are present in everyone

November 7, 2009
Leukemia treatment will be only the sixth in the world

September 23, 2009
A daughter's moving tale: How I gave my mum the gift of life

August 12, 2009
Daughter's cells save mother with leukaemia who was given just months to live

August 9, 2008
Cancer victim treated with daughter's cells in world first

July 14, 2008
Coronado: Cancer conquistador. Emerging company profile. BioCentury. 2008;16(32):A16. (A. Bouchie)